Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023


Revance Therapeutics, Inc. (RVNC) today announced that the company will release third quarter 2023 financial results on Wednesday, November 8, 2023, after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on the same day to discuss the results and provide a corporate update.

Individuals interested in listening to the conference call may do so by dialing (833) 470-1428 for U.S. and Canadian callers, and reference conference ID 509643 or from the webcast link in the investor relations section of the company's website at: www.revance.com.

A webcast replay will be available beginning November 8, 2023, at 4.30 p.m. PT / 7.30 p.m. ET to February 8, 2024 at 4.30 p.m. PT / 7.30 p.m. ET. To access the replay, please register via the webcast link on the events page. The webcast will be available in the investor relations section on the company's website for 90 days following the completion of the call.

About Revance

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences. Revance's portfolio includes DAXXIFY® (DaxibotulinumtoxinA-lanm) for injection and the RHA® Collection of dermal fillers in the U.S. Revance has also partnered with Viatris Inc. to develop a biosimilar to onabotulinumtoxinA for injection and Shanghai Fosun Pharmaceutical to commercialize DAXXIFY® in China.

Revance is headquartered in Nashville, Tenn., with additional office locations in Newark and Irvine, Calif. Learn more at www.Revance.com, www.RevanceAesthetics.com, www.DAXXIFY.com, www.hcp.DAXXIFYTherapy.com, or connect with us on LinkedIn.

"Revance" and the Revance logo, and DAXXIFY® are registered trademarks of Revance Therapeutics, Inc. Resilient Hyaluronic Acid® and RHA® are trademarks of TEOXANE SA. BOTOX® is a registered trademark of Allergan, Inc.


These press releases may also interest you

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 18:46
BOXABL Investors Have Now Indicated They Want to Invest Over $10MM in the Current Stock Offering! BOXABL Previously Sold Out the Reg A Crowdfund
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...

at 18:18
PATH Investors Have Opportunity to Lead UiPath Inc. Securities Fraud Lawsuit
Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UiPath Inc. ("UiPath" or the "Company") . Class Period: December 1, 2023 ? May 29, 2024 Lead...

at 18:15
Payfare Announces Completion of 2023 Annual Filings
Payfare Inc. ("Payfare" or the "Company")  today announces the completion of the filing of its audited annual financial statements, management's discussion and analysis, annual information form and related certifications, all for the year ended...

at 17:53
Partnership announcement between the Mohanji Foundation USA, World Consciousness Alliance, and The Diplomatic Club to promote Spiritual and Cultural Diplomacy Globally
The Mohanji Foundation, a global non-profit organization founded by Mohanji; World Consciousness Alliance, a Mohanji-founded platform for artists dedicated to raising awareness; and The Diplomatic Club, a non-political, non-profit organization...

at 17:45
Online Home Rental Services Market size is set to grow by USD 28.01 billion from 2024-2028, High real estate prices make homeownership unaffordable boost the market, Technavio
The global online home rental services market size is estimated to grow by USD 28.01 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 14.72% during the forecast period. High real estate prices make...

More news about Business...


News published on and distributed by: